Bausch & Lomb: Pay

Bausch & Lomb paid its 5 named executives $46.1M in total in FY2025 (Dec). CEO Brenton L. Saunders was paid $32.2M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Brenton L. SaundersChairman of the Board and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Sam A. EldessoukyExecutive Vice President and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
A. Robert D. BaileyExecutive Vice President and Chief Legal Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years
Dr. Yehia HashadExecutive Vice President of Research & Development and Chief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Andrew J. StewartPresident, Global Pharmaceuticals and International Consumer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
3 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 11 peers with pay on file was $14.7M. The CEO of Bausch & Lomb was paid $32.2M, 119% above the median.

  1. 1Bausch & Lomb
  2. 2Align Technology
  3. 3Edwards Lifesciences
  4. 4Zimmer Biomet Holdings
  5. 5Cooper Companies
  6. 6Viatris
  7. 7Resmed
  8. 8Agilent Technologies
  9. 9PERRIGO Co
  10. 10Dentsply Sirona
  11. 11Teleflex
  12. 12Organon & Co.
  13. 13Alcon Inc.Not disclosed
  14. 14DexcomNot disclosed
  15. 15Hologic, Inc.Not disclosed
  16. 16Jazz PharmaceuticalsNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.